Functional magnetic resonance imaging (fMRI) studies show that a single dose of methylphenidate increases activation in specific areas of the brain in children with attention-deficit/hyperactivity disorder (ADHD).
As irritable bowel syndrome (IBS) remains a complicated condition to treat with an etiology that’s still unknown, it’s difficult for physicians to find the best proven therapies among new remedies and the variety of pharmacological and nondrug options they have been trying for years.
Treatment with escitalopram reduces mental stress-induced myocardial ischemia (MSIMI) in patients with heart disease and MSIMI.
Men who had attention-deficit/hyperactivity disorder (ADHD) during childhood are at increased risk of obesity as adults.
With what we now know about opioid misuse and abuse, we need to take the necessary steps to ensure that only abuse-resistant/deterrent medications are used for our patients taking ER/LA opioid medications.